WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H565502
CAS#: N/A
Description: BA-53038B is Hepatitis B Virus Nucleocapsid Assembly Inhibitor. Drug resistant profile analyses indicated that BA-53038B most likely bound to the HAP pocket but obviously modulated HBV capsid assembly in a distinct manner.
Hodoodo Cat#: H565502
Name: BA-53038B
CAS#: N/A
Chemical Formula: C14H16ClNO
Exact Mass: 249.09
Molecular Weight: 249.738
Elemental Analysis: C, 67.33; H, 6.46; Cl, 14.19; N, 5.61; O, 6.41
This product is not in stock, which may be available by custom synthesis.
For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge).
Quote less than 1g will not be provided. To request quote, please email to sales @hodoodo.com or click below button.
Note: Price will be listed if it is available in the future.
Synonym: BA-53038B; BA 53038B; BA53038B
IUPAC/Chemical Name: (1R,6S,7r)-N-(3-Chlorophenyl)bicyclo[4.1.0]heptane-7-carboxamide
InChi Key: ZLCICHYECNOTGG-ITGUQSILSA-N
InChi Code: InChI=1S/C14H16ClNO/c15-9-4-3-5-10(8-9)16-14(17)13-11-6-1-2-7-12(11)13/h3-5,8,11-13H,1-2,6-7H2,(H,16,17)/t11-,12+,13+
SMILES Code: O=C([C@@H]1[C@@]2([H])CCCC[C@@]12[H])NC3=CC=CC(Cl)=C3
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO
Shelf Life: >3 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
More Info:
Biological target: | |
In vitro activity: | |
In vivo activity: |
The following data is based on the product molecular weight 249.74 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
Formulation protocol: | |
In vitro protocol: | |
In vivo protocol: |
1: Zhang X, Cheng J, Ma J, Hu Z, Wu S, Hwang N, Kulp J, Du Y, Guo JT, Chang J.
Discovery of Novel Hepatitis B Virus Nucleocapsid Assembly Inhibitors. ACS Infect
Dis. 2019 May 10;5(5):759-768. doi: 10.1021/acsinfecdis.8b00269. Epub 2018 Dec
19. PubMed PMID: 30525438; PubMed Central PMCID: PMC6510629.